|
Jan 20, 2026
|
Development Quality Assurance Specialist II
|
Billerica - Sun
|
|
|
Jan 29, 2026
|
DGM - Engineering Head (OSD)
|
Dadra - Plant
|
|
|
Feb 11, 2026
|
DGM - Engineering Sterile
|
Halol 1 - Plant
|
|
|
Feb 16, 2026
|
DGM - IT Security Engineering
|
Sun House - Corporate Office
|
|
|
Feb 16, 2026
|
DGM - IT Security Governance
|
Sun House - Corporate Office
|
|
|
Feb 16, 2026
|
DGM - IT Security Operations
|
Sun House - Corporate Office
|
|
|
Feb 14, 2026
|
DGM - Production
|
Baddi - Plant
|
|
|
Jan 29, 2026
|
DGM- Business Development
|
Sun House - Corporate Office
|
|
|
Jan 20, 2026
|
Digital Marketing Manager (Consumer Healthcare)
|
Sun House - Corporate Office
|
|
|
Jan 20, 2026
|
Director, Professional Relations - Cutaneous Oncology, West
|
FS-Sun
|
|
|
Jan 22, 2026
|
Director, Regulatory Affairs (Contract)
|
Sun Pharma Canada Inc.
|
|
|
Feb 14, 2026
|
Distribution BA
|
Sun House - Corporate Office
|
|
|
Feb 12, 2026
|
EHS Executive
|
Sun House - Corporate Office
|
|
|
Feb 12, 2026
|
Executive
|
Tandalja - R&D
|
|
|
Jan 22, 2026
|
Executive - MSTG Non orals
|
Halol 1 - MSTG - Formulation
|
|
|
Feb 2, 2026
|
Executive - Analytical Development
|
Tandalja - R&D
|
|
|
Feb 6, 2026
|
Executive - Analytical Development
|
Tandalja - R&D
|
|
|
Feb 13, 2026
|
Executive - Analytical Development
|
Tandalja - R&D
|
|
|
Jan 21, 2026
|
Executive - API R&D
|
Tandalja - R&D
|
|
|
Feb 3, 2026
|
Executive - Biotechnology
|
Tandalja - R&D
|
|
|
Feb 14, 2026
|
Executive - Biotechnology
|
Tandalja - R&D
|
|
|
Jan 23, 2026
|
Executive - Distribution
|
Sun House - Corporate Office
|
|
|
Feb 6, 2026
|
Executive - EM RA
|
Tandalja - R&D
|
|
|
Feb 1, 2026
|
Executive - FRD Non-Orals
|
Tandalja - R&D
|
|
|
Feb 1, 2026
|
Executive - FRD Orals
|
Tandalja - R&D
|
|